DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Epitranscriptomics in the glioma context: A brief overview
This article belongs to the Special Issue Updates on Epigenetics of Brain Tumor., [Simple Summary] Epitranscriptomics, the study of chemical modifications in RNA, has emerged as a crucial field in cellular regulation, adding another layer to the established landscape of DNA- and histone-based epigenetics. A wide range of RNA modifications, including N6-methyladenosine, pseudouridine, and inosine, have been identified across nearly all RNA species, influencing essential processes such as transcription, splicing, RNA stability, and translation. In the context of brain tumors, particularly gliomas, specific epitranscriptomic signatures have been reported to play a role in tumorigenesis. Despite growing evidence, the biological implications of various RNA modifications remain poorly understood. This review offers an examination of the main RNA modifications, the interplay between modified and unmodified molecules, how they could contribute to glioma-like phenotypes, and the therapeutic impact of targeting these mechanisms., Epitranscriptomics, the study of chemical modifications in RNA, has emerged as a crucial field in cellular regulation, adding another layer to the established landscape of DNA- and histone-based epigenetics. A wide range of RNA modifications, including N6-methyladenosine, pseudouridine, and inosine, have been identified across nearly all RNA species, influencing essential processes such as transcription, splicing, RNA stability, and translation. In the context of brain tumors, particularly gliomas, specific epitranscriptomic signatures have been reported to play a role in tumorigenesis. Despite growing evidence, the biological implications of various RNA modifications remain poorly understood. This review offers an examination of the main RNA modifications, the interplay between modified and unmodified molecules, how they could contribute to glioma-like phenotypes, and the therapeutic impact of targeting these mechanisms., This research was funded by Carlos III Health Institute, co-funded by the European Regional Development Fund (FEDER) (grant PI21/01067 to M.M.F. and A.F.F.). Horizon Europe Program (HORIZON-HLTH-2022-STAYHLTH-01-two-stage, ref 101080219 to P.S.-O.), Spanish Association Against Cancer for funding under grant PRYGN235109FERN to M.M.F., and to the Asturias Government (PCTI) for co-funding under the 2018–2023/FEDER framework (grant IDI/2021/000077 to M.M.F. and A.F.F.). Additionally, we recognize the support from the EU TRANSCAN-3 initiative (JTC 2023) (ref. AC24/00163)., Peer reviewed
Proyecto:
EC / HE 101080219
,
EC / H2020 964264